In silico and in vivo anti-inflammatory studies of curcuminoids, turmeric extract with zinc oxide, and eugenol
Purpose: To determine the anti-inflammatory activity of curcuminoids in comparison with that of eugenol in silico, and to determine the anti-inflammatory activity of wound dressings made from zinc oxide powder and liquid turmeric extract with a high curcuminoid content.
Methods: In silico studies were conducted, using Molegro Virtual Docker program, to predict the antiinflammatory potency of curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin) and eugenol against COX-2 receptors. In vivo studies to evaluate anti-inflammatory activity via TNFα expression, were carried out using thirty Wistar rats as subjects, divided into two groups: A (sacrificed on day 3) and B (sacrificed on day 7). Each group contained three subgroups (n = 5): A1, B1 were excised without a dressing as control subgroups; A2, B2 were excised followed by the application of zinc oxide with a turmeric extract dressing; and A3, B3 were excised followed by the application of zinc oxide with an eugenol dressing.
Results: The in silico studies confirmed the anti-inflammatory activity of curcumin (-132.905 kcal/mol), demethoxycurcumin (-130.265 kcal/mol), bisdemethoxycurcumin (-118.827 kcal/mol) in relation to the COX-2 receptor to be greater than that of eugenol (-78.718 kcal/mol). The in vivo studies of TNFα
expression showed that the levels of activity in the groups without dressings were significantly higher than in those with dressing (p<0.05), while the lowest TNFα expression were for zinc oxide with turmeric extract dressings.
Conclusion: The combination of zinc oxide with turmeric liquid extract has a higher anti-inflammatory effect than eugenol as demonstrated by both in vivo and in silico studies. This combination can, therefore, be used as an alternative to zinc oxide eugenol wound dressings.
Keywords: Anti-inflammatory, Curcuminoids, Turmeric, Zinc oxide, Eugenol, Wound dressing, In silico, TNFα
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.